DK1461319T3 - Quinolinderivater, syntesemetoder og medikamenter indeholdende nævnte derivater - Google Patents

Quinolinderivater, syntesemetoder og medikamenter indeholdende nævnte derivater

Info

Publication number
DK1461319T3
DK1461319T3 DK02795314T DK02795314T DK1461319T3 DK 1461319 T3 DK1461319 T3 DK 1461319T3 DK 02795314 T DK02795314 T DK 02795314T DK 02795314 T DK02795314 T DK 02795314T DK 1461319 T3 DK1461319 T3 DK 1461319T3
Authority
DK
Denmark
Prior art keywords
sub
derivatives
synthesis methods
coor
cooh
Prior art date
Application number
DK02795314T
Other languages
Danish (da)
English (en)
Inventor
Marie Bayle
Christophe Benard
Le Didier Desma
Michele Danet
Herve Leh
Jean-Francois Mouscadet
Frederic Subra
Fatima Zouhiri
Angelo Jean D
Bret Marc Le
Laurence Janson
Original Assignee
Bioalliance Pharma
Univ Paris Sud
Inst Nat Sante Rech Med
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioalliance Pharma, Univ Paris Sud, Inst Nat Sante Rech Med, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Bioalliance Pharma
Application granted granted Critical
Publication of DK1461319T3 publication Critical patent/DK1461319T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02795314T 2001-10-12 2002-10-14 Quinolinderivater, syntesemetoder og medikamenter indeholdende nævnte derivater DK1461319T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113209A FR2830863B1 (fr) 2001-10-12 2001-10-12 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
PCT/FR2002/003512 WO2003031413A1 (fr) 2001-10-12 2002-10-14 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Publications (1)

Publication Number Publication Date
DK1461319T3 true DK1461319T3 (da) 2009-08-03

Family

ID=8868255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02795314T DK1461319T3 (da) 2001-10-12 2002-10-14 Quinolinderivater, syntesemetoder og medikamenter indeholdende nævnte derivater

Country Status (10)

Country Link
US (2) US7064133B2 (enExample)
EP (1) EP1461319B1 (enExample)
JP (1) JP2005508350A (enExample)
AT (1) ATE430134T1 (enExample)
DE (1) DE60232186D1 (enExample)
DK (1) DK1461319T3 (enExample)
ES (1) ES2326115T3 (enExample)
FR (1) FR2830863B1 (enExample)
IL (2) IL161320A0 (enExample)
WO (1) WO2003031413A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
FR2839646B1 (fr) * 2002-05-17 2008-04-11 Bioalliance Pharma Utilisation de derives de quinoleine a effet anti-integrase et ses applications
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
ATE433974T1 (de) 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
JP2008542352A (ja) * 2005-06-01 2008-11-27 ビオアリアンス ファルマ キノリン化合物及び他のhiv感染治療薬を含む相乗作用のコンビネーション

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Also Published As

Publication number Publication date
US20060148849A1 (en) 2006-07-06
FR2830863B1 (fr) 2004-01-30
EP1461319B1 (fr) 2009-04-29
WO2003031413A1 (fr) 2003-04-17
FR2830863A1 (fr) 2003-04-18
JP2005508350A (ja) 2005-03-31
US7064133B2 (en) 2006-06-20
ATE430134T1 (de) 2009-05-15
US20040259911A1 (en) 2004-12-23
IL161320A0 (en) 2004-09-27
ES2326115T3 (es) 2009-10-01
IL161320A (en) 2009-09-01
DE60232186D1 (de) 2009-06-10
EP1461319A1 (fr) 2004-09-29

Similar Documents

Publication Publication Date Title
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
ATE180468T1 (de) Anthranilsäure derivate
DE69925141D1 (de) Chinazolin derivate
PA8548001A1 (es) Derivados aromaticos de acidos dicarboxilicos
DE60004637D1 (de) N2-phenylamidine derivate
DE69919212D1 (de) Aromatische amiden
EP1362846A4 (en) AMINOETHANOL DERIVATIVES
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
DE69309435D1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
RU97117350A (ru) Ингибитор гипертрофии интимы, применение оксиндолового производного для получения ингибитора гипертрофии интимы, композиция для ингибирования гипертрофии интимы, способ предупреждения и лечения гипертрофии интимы
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
IL161320A0 (en) Quinoline derivatives, synthesis method, and medicines containing said derivatives
PT911026E (pt) Derivados da creatina para a asma
AU7529487A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
PT1430047E (pt) Derivados de alquilaminopiridazinona substituida, processo para a sua preparacao e composicoes farmaceuticas que os contem
BR9813241A (pt) Derivados de guanidina substituìdos
DE60009517D1 (de) A-500359-derivate
CY1113801T1 (el) Παραγωγο κιναζολινης και φαρμακευτικο ειδος
AR033685A1 (es) Derivados del acido tetramico, coniosetina y derivados de la misma, procedimiento para su preparacion, medicamentos, procedimiento para la preparacion de medicamentos, empleo de dichos derivados para la preparacion de medicamentos
DK1175429T3 (da) Halogenderivater af 9-deoxo-9a-aza-9a-homoerythromycin A
ATE165362T1 (de) Neue derivate des 2-(1h)-chinolinones, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EA200200379A3 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
BR0014319A (pt) Derivados de pirimidina, processo para preparação dos derivados e drogas contendo o mesmos como o ingrediente ativo